Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
CA |
|
F
|
Fortitude Group Inc
OTC:FRTD
|
US |
|
Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT
IDX:JMAS
|
ID |
|
B
|
Besra Gold Inc
ASX:BEZ
|
MY |
|
S
|
SureNano Science Ltd
CNSX:SURE
|
CA |
|
Reliq Health Technologies Inc
XTSX:RHT
|
CA |
|
Antofagasta PLC
LSE:ANTO
|
UK |
|
Los Cerros Ltd
ASX:LCL
|
AU |
|
K
|
Kps Consortium Bhd
KLSE:KPS
|
MY |
|
Keramika Indonesia Assosiasi Tbk PT
IDX:KIAS
|
ID |
|
S
|
Srisawad Corporation PCL
SET:SAWAD
|
TH |
Bankruptcy Probability
Aurinia Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aurinia Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
107.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
74.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aurinia Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aurinia Pharmaceuticals Inc has total debt of 52.3m USD. This includes both short-term (0 USD) and long-term (52.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
